WallStSmart
KZIA

Kazia Therapeutics Ltd ADR

NASDAQ: KZIA · HEALTHCARE · BIOTECHNOLOGY

$13.64
+9.82% today

Updated 2026-04-30

Market cap
$135.07M
P/E ratio
P/S ratio
71.14x
EPS (TTM)
$-7.61
Dividend yield
52W range
$3 – $17
Volume
0.2M

Kazia Therapeutics Ltd ADR (KZIA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-14.44M$-14.63M$-20.10M$-20.60M$-16.61M$-8.70M$-7.35M$-8.79M$-5.71M$-5.76M$-11.98M$-11.43M$-8.66M$-6.71M$-8.81M$-9.11M$-22.76M$-15.16M$-9.58M$-13.28M
Capital expenditures$319385.00$299466.00$95114.00$94000.00$22000.00$56000.00$1000.00$10151.00$26976.00$97474.00$525000.00$11649.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Depreciation
Stock-based comp$1.20M$728000.00$651000.00$574000.00$401550.00$372000.00$517000.00$165000.00$246000.00$262000.00$637000.00$1.68M$1.16M$533000.00$653000.00
Free cash flow$-14.76M$-14.92M$-20.19M$-20.70M$-16.63M$-8.76M$-7.35M$-8.80M$-5.74M$-5.86M$-12.51M$-11.45M$-8.66M$-6.71M$-8.81M$-9.11M$-22.76M$-15.16M$-9.58M$-13.28M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$0.00$0.00$0.00$0.00$0.00